Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Achalasia

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Inability to swallow saliva, recurrent aspiration with hypoxia, profound dehydration or severe malnutrition needs urgent hospital assessment. New severe chest or upper-abdominal pain, fever, tachycardia, breathlessness or surgical emphysema after pneumatic dilation, myotomy or endoscopy suggests perforation and requires nil by mouth, immediate imaging, sepsis treatment and urgent upper-GI surgical contact. Rapidly progressive dysphagia, marked weight loss, anaemia or late-onset short history may be malignant pseudoachalasia and must not be reassured by a preliminary motility label.

Synopsis

Recognise achalasia, confirm impaired oesophagogastric junction relaxation, exclude pseudoachalasia and select safe specialist treatment with durable follow-up.

  • Achalasia is a primary motor disorder in which lower oesophageal sphincter relaxation fails and organised peristalsis is lost because inhibitory enteric neurones are impaired.
  • Dysphagia usually affects liquids as well as solids from early in the history, whereas purely progressive solid-food dysphagia first suggests a mechanical obstruction.
  • Regurgitation of bland retained food, nocturnal cough, recurrent chest infection, chest discomfort and unintentional weight loss are common but not individually diagnostic.
  • Upper gastrointestinal endoscopy is required to exclude cancer, peptic narrowing and eosinophilic oesophagitis, even when a barium study appears typical.
  • High-resolution manometry is the defining physiological test and distinguishes type I, type II and type III achalasia using the current Chicago classification framework.
  • A timed barium oesophagram quantifies emptying and oesophageal shape; a tapering bird-beak appearance supports the diagnosis but cannot exclude pseudoachalasia.
  • Pneumatic dilation, laparoscopic Heller myotomy and peroral endoscopic myotomy are effective definitive options selected through an experienced multidisciplinary service.
  • Type III spastic disease often favours a longer tailored myotomy, while type II generally has high response rates across established definitive treatments.
  • Botulinum toxin injection has limited durability and is generally reserved for people who cannot undergo more durable intervention or as a carefully chosen bridge.
  • Treatment reduces outflow resistance but does not restore normal peristalsis; recurrent dysphagia, reflux, aspiration and nutritional decline therefore require long-term review.

Key red flags

Pseudoachalasia pattern

A short rapidly worsening history, substantial weight loss, anaemia, older age at onset or unusual endoscopic resistance raises concern for junctional or proximal gastric malignancy.

Acute food and fluid obstruction

The patient cannot swallow saliva or maintain hydration and may have a fluid-filled dilated oesophagus, creating immediate aspiration and metabolic risk.

Respiratory complication

Night cough, recurrent pneumonitis, wheeze, voice change or falling oxygen saturation can result from overspill of retained oesophageal contents.

Iatrogenic perforation

Sudden persistent pain, tachycardia, fever, dyspnoea, pleural symptoms or subcutaneous gas after dilation or myotomy is an emergency until a leak is excluded.

Investigation priorities

01
Upper gastrointestinal endoscopyFirst step

Exclude a structural cause and inspect for retained contents or mucosal injury.

Management branches

ConfirmationProve primary achalasia safely

Liquids-and-solids dysphagia or retained-content regurgitation suggests an oesophageal motor disorder.

  1. Assess obstruction, aspiration, hydration, nutritional state and cancer alarm features; admit urgently when saliva cannot be handled or respiratory compromise is developing.
  2. Perform expert endoscopy with clearance of retained material as safely feasible, targeted biopsies of abnormalities and deliberate inspection of the cardia and proximal stomach.
  3. Confirm the motor phenotype with high-resolution manometry and add a timed barium oesophagram to define emptying and anatomy.
  4. If age, rapidity, weight loss or resistance is discordant, pursue CT, repeat endoscopy or endoscopic ultrasonography before calling the disorder idiopathic.

Key medicines

Endoscopic botulinum toxinAn advanced endoscopist injects the lower oesophageal sphincter using the service's current preparation, total dose and quadrant technique; there is no safe universal bedside regimen for unsupervised prescribing.Benefit often wanes and repeat injection may complicate later intervention through fibrosis. Confirm the diagnosis and exclude cancer first; consent for bleeding, perforation, infection and sedation risks under the local endoscopy protocol.
Proton pump inhibitor after sphincter disruptionUse a licensed full-dose PPI selected from the current BNF when post-myotomy reflux is expected, demonstrated or symptomatic, then adjust to objective findings and the lowest effective maintenance plan.Do not assume every post-treatment chest symptom is acid related. Recurrent retention, candidiasis, cancer and perforation require separate assessment; review adherence, interactions and long-term indication.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BSG oesophageal manometry and reflux monitoring guidelineUK framework for high-resolution manometry, motility diagnosis and adjunctive reflux testing.
  • BSG UK oesophageal dilatation guidelinePneumatic dilation technique, consent, perforation recognition and aftercare safeguards.
  • AUGIS regional achalasia POEM service specificationSpecialist multidisciplinary assessment, timed barium testing and treatment selection for POEM or surgery.
  • NICE suspected cancer recognition and referralCurrent escalation criteria for dysphagia and upper gastrointestinal cancer concern.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom